Mercury Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Mercury Laboratories Ltd. on BSE

Load latest

12 Nov 2022

Company Update

Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Meeting Updates

BSE India

Disclosure of information under Regulation 30(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 on Creation of new facility for manufacturing Small Volume Parenteral(SVPs) at Jarod

pdf

Mercury Laboratories Ltd.

11 Nov 2022

Result

Mercury Laboratories Ltd - 538964 - Unaudited Financial Results For The Quarter And Half Year Ended …

BSE India

Unaudited Financial Results for the Quarter and Half Year ended on September 30, 2022

pdf

Mercury Laboratories Ltd.

11 Nov 2022

Board Meeting

Mercury Laboratories Ltd - 538964 - Board Meeting Outcome for Outcome Of The Board Meeting - …

BSE India

In thevmeeting of Board of Directors held on November 11, 2022 the Board of Directors approved following agenda Item. 1. The unaudited financial results of the Company along with limited review report issued by Statutory Auditor for the quarter and half year ended on September 30, 2022. 2. Creation of new facility for manufacturing of small volume parenteral having capacity of manufacturing of 75 million annually at Unit No 2 at Baroda - Halol Road, Jarodiapura, Jarod with an estimated cost of INR 30 Crores.

pdf

Mercury Laboratories Ltd.

02 Nov 2022

Board Meeting

Mercury Laboratories Ltd - 538964 - Board Meeting Intimation for Unaudited Financial Results Of The Company …

BSE India

Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 ,inter alia, to consider and approve Unaudited financial results of the Company for the quarter ended on September 30, 2022 and To consider and approve any other items of Agenda, if any

pdf